The research is planned to take place at the newly licensed Lumir Lab, which is located on the Hebrew University campus. According to the article, there are over 180 million women worldwide who suffer from the condition. According to Gynica, the female human reproductive organs contain the most receptors for cannabinoids, only coming second to the human brain in terms of that receptivity.
“Currently, the vast majority of the cannabis products available in various markets have no scientific basis, which prevents the medical community from supporting the legitimacy of treatments based on cannabis,” said Yotam Hod. “We aim to provide tools and solutions that are not currently available.”